Article | October 23, 2015

6 Best Practices in Interactive Response Technology (IRT) Implementation In Asia

Source: Almac Clinical Technologies
6 Best Practices in Interactive Response Technology (IRT) Implementation In Asia

By Jim Murphy, President & Managing Director, Almac Clinical Technologies

In 2014, 23% of clinical trials were conducted in the Asia Pacific (APAC) region, and that percentage is destined to climb. To keep up with this pace, APAC study managers, investigators, and supply chain managers (who have, until today, managed manual record-keeping in clinical trials) need to automate. Interactive Response Technology (IRT) presents an opportunity for pharmaceutical sponsors conducting clinical trials in the APAC region to significantly improve productivity and data integrity.

IRT systems, which were first introduced about 20 years ago, deliver a wide range of applications for managing patient interactions and drug supplies throughout the trial lifecycle. In serving sponsors, drug depots, and sites, they automate patient randomization, product inventory management, patient tracking, study reporting and drug accountability and reconciliation.